The Valley Desk

NCT00635089 · Interventional trial

Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis

Overall registry status Completed

Phase 3

Conditions Eosinophilic Esophagitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov